Lyra Therapeutics (LYRA) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-7.5
-5.04
-2.58
-0.12

Details

Expected EPS
-5.526667
Actual EPS
-5.51
Surprise EPS
0.02
Surprise Percent
+0.3%

Description

Lyra Therapeutics (LYRA) has reported earnings of -5.51 per share for Q3 2025.

0 Comments

Share your thoughts